Letrozole
-
Molecular Structure
Detailed Description
IUPAC NAME-4,4'-((1H-1,2,4-triazol-1-yl)methylene)dibenzonitrile
MOLECULAR FORMULA-C17H11N5
MOLAR MASS-285.303 g/mol
Letrozole is approved by the United States Food and Drug Administration for the treatment of local or metastatic breast cancer that is hormone receptor positive or has an unknown receptor status in postmenopausal women

- Letrozole